Gujarat Kidney and Super Speciality Ltd has received approval for the 100% acquisition of Parekhs Hospital in Ahmedabad at a cost of ₹770 million. The move strengthens GKSSL’s presence in Gujarat’s healthcare sector, expands patient reach, and aligns with its long-term growth strategy to deliver advanced super-speciality services.
Gujarat Kidney and Super Speciality Ltd (GKSSL) has announced that it has received approval for the 100% acquisition of Parekhs Hospital in Ahmedabad, with the deal valued at ₹770 million. This strategic move underscores the company’s aggressive expansion plans in Gujarat’s healthcare sector, following its recent IPO and ongoing investments in super-speciality services.
Key highlights of the announcement include:
-
The acquisition cost has been finalized at ₹770 million, reflecting GKSSL’s commitment to strengthening its footprint in Ahmedabad’s healthcare market.
-
Parekhs Hospital, a well-established multi-speciality facility, will now be fully integrated into GKSSL’s network, enhancing its capacity and service offerings.
-
The deal aligns with GKSSL’s broader strategy to expand across Gujarat, including setting up new hospitals in Vadodara and investing in advanced medical technologies such as robotics.
-
Analysts note that the acquisition will provide GKSSL with greater patient reach, diversified services, and improved brand visibility, positioning it as a rising player in India’s super-speciality healthcare space.
-
The company emphasized that this acquisition is part of its long-term growth roadmap, aimed at delivering high-quality, accessible healthcare across the state.
This acquisition marks a significant milestone for GKSSL, reinforcing its ambition to become a leading super-speciality healthcare provider in India.
Sources: Reuters, ANI News, Moneycontrol